Omega-3-acid Ethyl Esters Patent Expiration
Omega-3-Acid Ethyl Esters is Used for managing lipid levels. It was first introduced by Waylis Therapeutics Llc
Omega-3-acid Ethyl Esters Patents
Given below is the list of patents protecting Omega-3-acid Ethyl Esters, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lovaza | US7732488 | Pharmaceutical composition comprising low concentrations of environmental pollutants |
Jan 30, 2025
(Expired) | Waylis Therap |
| Lovaza | US5656667 | Fatty acid composition |
Apr 10, 2017
(Expired) | Waylis Therap |
| Lovaza | US5502077 | Fatty acid composition |
Mar 26, 2013
(Expired) | Waylis Therap |
Omega-3-acid Ethyl Esters's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List